Tissue culture plants and bio informatics company Mavens Biotech Ltd said it signed a memorandum of understanding (MoU) with Bangalore-based Garuda Group to develop projects in real-estate, township development and other infrastructure related areas.
This joint venture (JV) has already identified three projects in and around the Bangalore city for the development of a mall, hotel cum convention centre and large township.
On Monday, Mavens Biotech shares increased 5% to Rs20 on the Bombay Stock Exchange, while the Sensex closed 1.2% higher at 18,081 points.
Gurgaon-based GlaxoSmithKline Consumer Healthcare Ltd said its net profit for second quarter ended 30 June 2010 increased to Rs71.8 crore from Rs55.1 crore a year ago.
During the April-June quarter, its total revenue increased to Rs552.5 from Rs486.3 crore, it said in a regulatory filing.
On Monday, GlaxoSmithKline Consumer shares ended 0.9% up to Rs1,785 on the Bombay Stock Exchange, while the Sensex closed 1.2% higher at 18,081 points.
India Cements Ltd said its first quarter net profit fell to Rs25 crore as against the net profit of Rs144.3 crore during the same quarter last year.
The company's total revenue decreased to Rs909.2 crore in the June 2010 quarter from Rs960.2 crore same quarter a year ago.
On Monday, India Cements shares ended 1.6% down to Rs104 on the Bombay Stock Exchange, while the Sensex closed 1.2% higher at 18,081 points.